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Chinese herbal medicine (CHM) has been commonly used for treating insomnia in Asian countries for centuries. The aim of
this study was to conduct a large-scale pharmaco-epidemiologic study and evaluate the frequency and patterns of CHM use in
treating insomnia. We obtained the traditional Chinese medicine (TCM) outpatient claims from the National Health Insurance in
Taiwan for theyear 2002. Patients with insomniawere identiﬁed from the diagnostic code of International Classiﬁcation of Disease
among claimed visiting ﬁles. Corresponding prescription ﬁles were analyzed, and an association rule was applied to evaluate the
co-prescription of CHM. Results showed that there were 16134 subjects who visited TCM clinics for insomnia in Taiwan during
2002 and received a total of 29801 CHM prescriptions. Subjects between 40 and 49 years of age comprised the largest number of
those treated (25.3%). In addition, female subjects used CHMs for insomnia more frequently than male subjects (female:male
= 1.94:1). There was an average of 4.8 items prescribed in the form of either an individual Chinese herb or formula in a single
CHM prescription for insomnia. Shou-wu-teng (Polygonum multiﬂorum) was the most commonly prescribed single Chinese herb,
while Suan-zao-ren-tang was the most commonly prescribed Chinese herbal formula. According to the association rule, the most
commonly prescribed CHM drug combination was Suan-zao-ren-tang plus Long-dan-xie-gan-tang, while the most commonly
prescribed triple drug combination was Suan-zao-ren-tang, Albizia julibrissin,a n dP. multiﬂorum. Nevertheless, further clinical
trials are needed to evaluate the eﬃcacy and safety of these CHMs for treating insomnia.
1.Introduction
Insomnia is a common health problem in the general
population worldwide [1]. Individuals with insomnia may
suﬀer from the inability to fall asleep, remain asleep, or
have non-restorative sleep, thereby inﬂuencing their daytime
functioning [2]. From an etiologic point of view, this sleep
disorder can be characterized as primary insomnia, which
does not result from physical or mental factors [3]. In
contrast, secondary insomnia is caused by factors, such
as psychological, psychosocial, or drug dependency [4].
However, occasionally there is no deﬁnite causal relationship
between precipitating factors and the occurrence of insom-
nia; hence, this form of insomnia could be considered a co-
morbid condition [5].
Therapy for insomnia in Western medicine is mainly
based on prescribed medications such as benzodiazepines,
antidepressants, anticonvulsants, or over-the-counter anti-
histamines [5]. However, these medications are sometimes
associated with adverse eﬀects and are not suitable for long-
term use [5].Inadditiontotheaforementionedmedications,
there are behavioral and cognitive therapies or alternative
and complementary treatments utilized in Western coun-
tries, such as melatonin, l-tryptophan, herbal passionﬂower,
valerian and St John’s wort [5, 6].
In Asian countries, traditional Chinese medicine (TCM)
has been widely used for centuries [7–10]. Accordingly,
Chinese herbal medicines (CHMs) are frequently used in
the treatment of insomnia. Several studies have shown that
treatment with CHMs eﬀectively improve sleep quality,
prolong sleep duration and exhibit fewer side eﬀects than
Western medicines, including lethargy, dry mouth and
dizziness [11–13]. However, there have been no large-
scale pharmaco-epidemiologic studies of CHMs for the2 Evidence-Based Complementary and Alternative Medicine
treatment of insomnia. With respect to their use in clinical
practice, prescriptions of CHMs for insomnia largely reﬂect
the experience of the Chinese herbal doctor or what is
recommended by traditional Chinese texts. Therefore, the
optimal CHM prescription for the treatment of insomnia
remains to be clinically or scientiﬁcally established.
In Taiwan, the National Health Insurance (NHI) pro-
gram has reimbursed the medical expenses incurred for
Western medicines for nearly all residents since 1995; NHI
has provided for 22520776 beneﬁciaries as of the end of
2002, which includes nearly 97% of the total population
in Taiwan [14]. The use of TCM has been reimbursed by
the NHI since 1996, and the people of Taiwan are free to
choose between practitioners of Western medicine or TCM.
In addition, the Taiwanese are allowed to visit primary-care
clinics or hospitals without a referral. Because all claim data
areavailabletoresearchersinanelectronicform,alarge-scale
survey of pharmaco-epidemiologic issues can be feasibly
conducted. The aim of the current study was to explore the
frequencyandpatternofCHMuseinsubjectswithinsomnia
by analyzing the NHI database for the year 2002 in Taiwan.
2.SubjectsandMethods
2.1. Data Sources. T h eN H Ip r o g r a mi nT a i w a nw a si m p l e -
mented in 1995, and the NHI Bureau began to release
all claims data in electronic form to the public under
the National Health Insurance Research Database (NHIRD)
project. The structure of the claim ﬁles is described
in detail at the NHIRD Web site and in our previous
publications [10]. In brief, we obtained the database of
TCM claims from NHIRD, including the oﬃce-visit ﬁles
and corresponding prescription ﬁles (CM CD2002.DAT and
CM OO2002.DAT), for the year 2002 in Taiwan. The oﬃce-
visit ﬁles recorded the dates of encounters, the medical-
care facilities and specialties, the patient genders, the patient
birth dates, and up to three diagnoses according to the
International Classiﬁcation of Diseases, Ninth Revision,
Clinical Modiﬁcation (ICD-9-CM). For privacy protection,
the unique identiﬁers of the patients and institutions were
scrambled cryptographically to assure anonymity. The pre-
scription ﬁles contained the prescription records for the
CHMs corresponding to the patient’s oﬃce visits. A CHM
prescription contained one or more Chinese herbs or herbal
formulae. A single Chinese herb or herbal formula was
processed into powder or ﬁne granules in Taiwan, and were
easily mixed and dispensed into small packages so that each
prescription could be taken one at a time.
All TCM treatments covered by the NHI are provided
only in ambulatory care clinics of Taiwan, and there is
no inpatient care for TCM recipients. In addition, only
licensed TCM physicians are eligible for reimbursement.
The insurance beneﬁts of TCM in Taiwan include CHMs,
acupunctureandtraumatologicmanipulativetherapy,which
is especially designed for joint dislocations.
2.2. Study Design. Although the concept of disease states in
TCM is quite diﬀerent from that in Western medicine, the
TCM physicians in Taiwan have been requested to code for
oﬃce-visit claims with a diagnosis based on the ICD-9-CM
designation (no more than three diagnostic codes at each
visit).Inthisstudy,wechosethedataofsubjectswithasingle
diagnostic code for insomnia (i.e., ICD-9-CM code 780.52)
among the TCM visits.
Patient management via TCM often includes a single
prescription from a TCM physician that may contain an
individualChineseherbormultipleherbsofvariousdosages.
Examplesincludeacompound(Fu-Fang),aclassicalformula
(regimen, remedy or Fang-Ji) that is a combination of com-
patible Chinese herbs in ﬁxed dosages according to classical
or well-known texts of Chinese medicine, a classic formula
combined with some Chinese herbs (Chia-Chien-Fang) or
several formulae combined together with or without one or
several Chinese herbs.
2.3. Data Analysis. The database software, IBM DB2 8.1,
was used for data linkage analysis and processing. Regular
statistics were displayed for the use frequency and patterns of
CHM prescriptions for insomnia. Association rule mining,
originally developed in the 1990s to identify which groups or
setsofitemswerelikelytobepurchasedtogether,wasapplied
to analyze the prescription rates of the Chinese herbals for
insomnia [15, 16]. The association rule was applied for
the prescription analysis in the following manner: when a
physician prescribed drug A (or drugs A1 and A2, drugs A1,
A2 and A3, etc.), drug B is also prescribed in X% of cases,
and this co-prescribing is present in Y% of all prescriptions.
The support factor is the ratio of co-prescriptions of all
prescriptions(i.e.,Y%intheaboveexample).Theconﬁdence
factor is the ratio of co-prescriptions to prescriptions for
drug A (i.e., X% in the above example). When executing
the program to identify association rules in our data set, we
chose 0.5% as the minimum support factor and 30% as the
minimum conﬁdence level [17].
3. Results
Among the 22520776 valid beneﬁciaries of the NHI at the
end of 2002 in Taiwan, 6221426 subjects (27.6%) used
TCM during that year and 16134 subjects (0.3%) visited
TCM clinics and exclusively used CHMs for insomnia.
Among these subjects with insomnia, there were 29801
CHM prescriptions. The peak age of these subjects with
insomnia treated by TCM was between 40 and 49 years
(25.3%), followed by 30–39 years (23.8%) and 50–59
years (17.0%; Table 1). In addition, female subjects used
CHM for insomnia more frequently than male subjects
(female:male=1.94:1).
The most common individual Chinese herb prescribed
for insomnia was Polygonum multiﬂorum (Shou-wu-teng;
23.8%), followed by Ziziphus spinosa (Suan-zao-ren; 18.3%),
Poria cocos (Fu-shen; 13.3%), Albizia julibrissin (He-huan-
pi; 10.0%), Ostrea gigas (Mu-li; 8.1%), Polygala tenuifolia
(Yuan-zhi; 8.0%), Saliva miltiorrhiza (Dan-shen; 7.5%),
Scutellaria baicalensis (Huang-qin; 7.4%), Coptis chinensis
(Huang-lian; 5.4%) and Lilium brownii (Bai-he; 5.1%;
Table 2).Evidence-Based Complementary and Alternative Medicine 3
Table 1: Age-speciﬁc frequency for the use of Chinese herbal medicines in patients with insomnia under the National Health Insurance in
Taiwan during 2002.
Age (years) Subjects with insomnia using Chinese herbal medicines
Number of patients (%) Male (%) Female (%)
0–9 65 (0.4%) 27 (0.17%) 38 (0.23%)
10–19 373 (2.3%) 151 (0.94%) 222 (1.38%)
20–29 2131 (13.2%) 677 (4.20%) 1454 (9.01%)
30–39 3839 (23.8%) 1273 (7.90%) 2566 (15.90%)
40–49 4074 (25.3%) 1381 (8.56%) 2693 (16.70%)
50–59 2743 (17.0%) 846 (5.24%) 1897 (11.76%)
60–69 1694 (10.5%) 596 (3.69%) 1098 (6.81%)
70–79 988 (6.1%) 447 (2.77%) 541 (3.35%)
≥80 227 (1.4%) 96 (0.60%) 131 (0.81%)
Total 16134 (100%) 5494 (34.05%) 10640 (65.95%)
Male:female=1:1.94.
Suan-zao-ren-tang (31.2%) was the most commonly
prescribed Chinese herbal formula for subjects with
insomnia, followed by Jia-wei-xiao-yao-san (21.2%), Tian-
wang-bu-xin-dan (15.6%), Chai-hu-jia-long-gu-mu-li-tang
(12.4%), Wen-dan-tang (11.6%), Gan-mai-da-zao-tang
(11.5%),Gui-pi-tang(6.6%),Zhi-bai-di-huang-wan(6.0%),
Long-dan-xie-gan-tang (4.9%) and Qing-xin-lian-zi-yin
(4.6%; Table 3).
There was an average of 4.8 Chinese herbs in a single
prescription for subjects with insomnia. The most common
number of herbal components in the prescribed Chinese
herbal formulae or individual Chinese herbs for subjects
with insomnia in Taiwan was six (20.0%), followed by
ﬁve (17.3%) and three (15.8%; Figure 1). According to
the association rule, the most commonly prescribed CHM
drug combination for treating insomnia was Suan-zao-ren-
tang with Long-dan-xie-gan-tang (Table 4), while the most
commontripledrugcombinationwasSuan-zao-ren-tang,A.
julibrissin,a n dP. multiﬂorum (Table 5). With regard to the
most common quadruple drug combination, Suan-zao-ren-
tang, Chai-hu-jia-long-gu-mu-li-tang, P. multiﬂorum,a n d
Poria cocos accounted for 1.6% of all prescriptions, while
the most common quintuple drug combination was Suan-
zao-ren-tang, Gan-mai-da-zao-tang, P. multiﬂorum, Poria
cocos and Coptis chinensis, which accounted for 1.6% of all
prescriptions.
4. Discussion
The current study is the ﬁrst large-scale survey of the
use of CHMs for the treatment of insomnia in a Chinese
population. This investigation was conducted by analyzing
the computerized claim dataset of TCM oﬃce visits covered
by the NHI in Taiwan. Our results showed that females
were the more common TCM users (female:male=1.94:1),
which is in agreement with the results of a meta-analysis
reported by Zhang and Wing [18]. We also found that nearly
one half of the subjects (49%) that used TCM for insomnia
were 30–49 years of age. Several factors, such as psychosocial
problems, physical disorders or a patient’s inclination toward
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Figure 1: Relationship between the number of prescriptions in
Taiwan in 2002 and the number of single herbs or combined
ingredients of Chinese herbal formulae.
TCM herbs, might account for the high prevalence rate of
CHM use in this group [10, 19–21].
Clearly, a variety of CHM formulae or individual herbal
drugs have been used to treat insomnia according to the
practitioners’ personal experiences or from the records of
traditional Chinese texts. However, it remains unclear which
of the Chinese herbal formulae or drugs used are the most
eﬀective in treating insomnia in clinical practice. Studies
examining drug utilization and prescribing patterns through
a large-scale survey of clinical practices can serve as an
eﬀective tool for investigating the clinical pharmacology of
these compounds. In addition, these studies can provide
relevant information for ways to screen and identify poten-
tially eﬀective CHM for treating insomnia [31, 32]. Once the4 Evidence-Based Complementary and Alternative Medicine
Table 2: The top 10 individual Chinese herbs prescribed for insomnia in Taiwan during 2002.
Chinese single herb
(Chinese name) Generic name Number of
prescriptions Percentage
Shou-wu-teng P. multiﬂorum 7093 23.8
Suan-zao-ren Zs p i n o s a 5459 18.3
Fu-shen Poria cocos 3975 13.3
He-huan-pi A. julibrissin 2982 10.0
Mu-li O. gigas 2424 8.1
Yuan-zhi Polygala tenuifolia 2373 8.0
Dan-shen S. miltiorrhiza 2248 7.5
Huang-qin Scutellaria baicalensis 2210 7.4
Huang-lian Coptis chinensis 1595 5.4
Bai-he L. brownii 1518 5.1
Total prescription numbers =29801.
Table 3: The top 10 Chinese herbal formulae prescribed for insomnia in Taiwan during 2002.
Chinese herbal formulae
(Chinese name) Ingredients Number of
prescriptions (%)
Suan-zao-ren-tang A. asphodeloides, G. uralensis (Gur), Ligusticum chuanxiong, P. cocos (Pco), Z.
spinosa (Zsp) 9299 (31.2%)
Jia-wei-xiao-yao-san
(Dan-zhi-xiao-yao-san)
Angelica sinensis (Asi), Atractylodes macrocephala (Ama), Bupleurum chinense
(Bch), Gardenia jasminoides (Gja), Gur, Mentha haplocalyx, Paeonia lactiﬂora,
Paeonia suﬀruticosa (Psu), Pco, Zingiber oﬃcinale (Zof)
6303 (21.2%)
Tian-wang-bu-xin-dan
Asi, Asparagus cochinchinensis, Codonopsis pilosula (Cpi), Ophiopogon japonicus
(Oja), Platycladus orientalis, Platycodon grandiﬂorum, Polygala tenuifolia (Pte),
Pco, Rehmannia glutinosa (Rgl), S. miltiorrhiza, Schisandra chinensis,
Scrophularia ningpoensis, Zsp
4656 (15.6%)
Chai-hu-jia-long-gu-mu-li-tang
Bupleurum chinense, Cinnamomum cassia, Cpi, Os Draconis, O. gigas, Pinellia
ternate (Pter), Pco, Rheum palmatum, Scutellaria baicalensis (Sba), Zof, Z. jujuba
(Zju),
3704 (12.4%)
Wen-dan-tang Citrus aurantium, Gur, Phyliostachys nigra, Pter, Pco, Zof, Zju 3445 (11.6%)
Gan-mai-da-zao-tang Gur, Triticum aestivum, Zju 3427 (11.5%)
Gui-pi-tang Asi, Astragalus membranaceus (Ame), Ama, Aucklandia costus, Cpi, Dimocarpus
l o n g a n ,G u r ,P t e ,P c o ,Z o f ,Z j u ,Z s p 1960 (6.6%)
Zhi-bai-di-huang-wan Alisma plantago (Apl), Anemarhena asphodeloides, Cornus oﬃcinalis, Dioscorea
o p p o s i t e ,P s u ,P h e l l o d e n d r o nc h i n e n s e ,P c o ,R g l 1789 (6.0%)
Long-dan-xie-gan-tang Akebia trifoliate, Apl, Asi, Bch, Gja, Gentiana scabra, Gur, Plantago asiatica (Pas),
Rgl, Sba 1470 (4.9%)
Qing-xin-lian-zi-yin Ame, Gur, Lycium chinense, Nelumbo nucifera, Oja, Panax ginseng, Pas, Pco, Sba 1370 (4.6%)
Total prescription numbers =29801.
eﬀective Chinese herbs for treating insomnia are identiﬁed
and conﬁrmed in clinical trials, further research can be
conducted in order to identify the bioactive ingredients of
these herbs.
Polygonum multiﬂorum (Shou-wu-teng), the most com-
monly prescribed Chinese herb for subjects with insomnia,
has been reported to have anti-inﬂammatory activity [33],
an anti-atherosclerogenic eﬀect [34] and exhibits neuropro-
tective eﬀects in animal studies [35]. Shou-wu-teng is the
climbing vine of P. multiﬂorum. According to TCM texts,
its root can be used as medicine. However, the functions
of the vine and root are diﬀerent. Until the Qing Dynasty,
the book “Ben cao Zheng Yi” of Chang Shan-Lei (1873–
1934) indicated that Shou-wu-teng can treat insomnia. He
stated that “there is a legend that the vine of this P.
multiﬂorum will interconnect with each other at night, thus
implying a sleep-promoting eﬀect”. Although Shou-wu-teng
is often used to treat insomnia during clinical practice, no
clinical research exists in the Western literature verifying its
sedative or anxiolytic eﬀects. Importantly, there are some
case reports demonstrating that Shou-wu-teng is associated
with hepatotoxicity [36, 37]. Nevertheless, further clinical
studiesareneededtoevaluatetheeﬃcacyandsafetyofShou-
wu-teng for treating insomnia in a clinical setting.Evidence-Based Complementary and Alternative Medicine 5
Table 4: The most common prescription patterns for combination
Chinese herbs in a single prescription for subjects with insomnia in
Taiwan during 2002.
Chinese herbal formulae or single
herbs
Support
(%)
Number of
prescriptions
Suan-zao-ren-tang,
Long-dan-xie-gan-tang 2.0 597
Jia-wei-xiao-yao-san, Wen-dan-tang 2.0 593
Suan-zao-ren-tang,
Zhi-bai-di-huang-wan 1.5 447
Wen-dan-tang,
Chai-hu-jia-long-gu-mu-li-tang 1.4 422
Jia-wei-xiao-yao-san,
Zhi-bai-di-huang-wan 1.3 379
Zhi-bai-di-huang-wan, Z. spinosa 1.2 364
Jia-wei-xiao-yao-san, Corydalis
turtschaninovii 1.1 327
Suan-zao-ren-tang, Gui-pi-tang 1.1 319
Jia-wei-xiao-yao-san,
Liu-wei-di-huang-wan 1.1 317
Total prescription numbers = 29801.
Table 5: The most common prescription pattern for the triple drug
combination of Chinese herbs in a single prescription for insomnia
in Taiwan during 2002.
Chinese herbal formulae or single herbs Support
(%)
Number of
prescriptions
Suan-zao-ren-tang, A. julibrissin, P.
multiﬂorum 2.1 618
Z. spinosa, P. multiﬂorum, A. julibrissin 1.4 428
Tian-wang-bu-xin-dan, P. multiﬂorum,
A. julibrissin 1.3 377
L. brownie, P. multiﬂorum, A. julibrissin 1.1 321
Jia-wei-xiao-yao-san, P. multiﬂorum, A.
julibrissin 1.1 320
P. cocos, P. multiﬂorum, A. julibrissin 1.0 287
Suan-zao-ren-tang,
Jia-wei-xiao-yao-san, P. multiﬂorum 0.9 279
Suan-zao-ren-tang,
Jia-wei-xiao-yao-san,
Tian-wang-bu-xin-dan
0.9 275
Z. spinosa, Poria cocos, Polygala
tenuifolia 0.9 266
Suan-zao-ren-tang, P. multiﬂorum, O.
gigas 0.9 256
Total prescription numbers =29801.
The second most commonly used Chinese herb for
subjects with insomnia in our study was Suan-zao-ren (Z.
spinosa). It is the chief ingredient in the formula of Suan-
zao-ren-tang. In an animal model, Peng et al. [22]r e p o r t e d
thatSuan-zao-renhadasedativeeﬀectathigherdosesandan
anxiolytic eﬀect at lower doses. In addition, Zhang et al. [23]
indicated that Jujuboside A, one of the components of Suan-
zao-ren, produced its sedative-hypnotic eﬀects through
eﬀecting the actions of anti-calcium-binding proteins and
it inhibited the glutamate-mediated excitatory signaling
pathway in the hippocampus. Jiang et al. [24] also reported
that saponins, the main bioactive components of Suan-zao-
ren,couldprolongthesleepingtimeinducedbybarbiturates.
In addition, Ma et al. [25] revealed that sanjoinine A,
an alkaloid compound of Suan-zao-ren, might regulate
GABAergic neurons and further increase the sleeping time
and decrease the sleep latency induced by pentobarbital.
Notably, there was a case report indicating that Suan-
zao-ren could interact with the antidepressant, venlafaxine
(Efexor), thereby leading to an acute serotonin reaction
[38].
Other commonly prescribed individual Chinese herbs
usedforinsomniafoundinourstudyincludedthefollowing:
Polygala tenuifolia [26]a n dS. miltiorrhiza [27], which were
reported to have sedative eﬀects; and A. julibrissin [39],
Scutellaria baicalensis [40, 41]a n dCoptis chinensis [42],
whichwerereportedtohaveanxiolyticeﬀectsinanimalstud-
ies. Several individual Chinese herbs not included in our top
10 commonly used regimens are still used for the treatment
of insomnia in clinical practice. Some of these Chinese herbs
have been reported to have anxiolytic-like eﬀects, including
Corydalis turtschaninovii (Yan-hu-suo) [43], Ginkgo biloba
(Bai-guo) [44], Gardenia jasminoides (Zhi-zi) [45], and
Gastrodia elata (Tian-ma) [46]. Others have been reported
tohavehypnoticeﬀects,suchasStephaniatetrandra(Fang-ji)
[28].Certainly,theseChineseherbsarealsoworthyoffurther
investigation regarding their clinical eﬃcacy and safety in
treating insomnia.
In the current study, Suan-zao-ren-tang was the most
commonly prescribed Chinese herbal formula used for the
treatment of insomnia. The use of Suan-zao-ren-tang was
noted in the ancient Chinese book, Synopsis of Prescriptions
of the Golden Chamber, written by Chang Chung Ching
(AD 150–219), and has been used to treat insomnia for
centuries. In the original article of this book, it stated the
following [47]: “Consumptive disease with restlessness and
insomnia can be treated with Decoction of Semen Ziziphi
Spinosae”. In one clinical trial from Taiwan, Chen and Hsieh
[11] concluded that Suan-zao-ren-tang improved the quality
of sleep without generating signiﬁcant side eﬀects. In one
survey from Hong Kong, Suan-zao-ren-tang was also the
mostcommoningredientfoundinover-the-countersleeping
pills [48]. With regard to the basic researches examining the
treatment of insomnia, current pharmacologic approaches
have largely focused on the activity of gamma-aminobutyric
acid A (GABA)A, one of the inhibitory neurotransmitters
in the central nervous system [49]. In an experimental rat
model, Suan-zao-ren-tang was shown to increase non-rapid
eye movement sleep, and the mechanism was thought to be
mediated through the stimulation of GABAA and serotonin
receptors [50, 51]. Importantly, Suan-zao-ren-tang is com-
posed of ﬁve ingredients. Suan-zao-ren, the chief ingredient
of Suan-zao-ren-tang, has been reported to have a sedative-
hypnotic eﬀect in animal studies [22–25]. Other ingredients
of Suan-zao-ren-tang include Anemarrhena asphodeloides,
Poria cocos, Ligusticum chuanxiong and Glycyrrhiza uralensis
(Radix glycyrrhizae). The latter herb has been shown to6 Evidence-Based Complementary and Alternative Medicine
Table 6: Summary of major constituents and pharmacologic activities of Chinese single herbs prescribed for insomnia with sedative and
hypnotic eﬀects.
Chinese single herb
(generic name) Major constituent Pharmacologic activity
Z. spinosa Spinosin and jujubosides Increases the hexobarbital-sleeping time and decreases the locomotor activity
[22]
Jujuboside A Inhibits the glutamate-mediated excitatory signal pathway in the hippocampus
[23]
Saponins Decreases monoaminergic system activity [24]
Sanjoinine A Regulates GABA-ergic systems and further increases the sleeping time and
decreases the sleep latency induced by pentobarbital [25]
Polygala tenuifolia 3,4,5-Trimethoxycinnamic
acid Suppresses norepinephrine in the locus coeruleus of rats [26]
Salvia miltiorrhiza Miltirone Central benzodiazepine receptor partial agonist [27]
Stephania tetrandria Tetrandrine Eﬀe c to ns e r o t o n e r g i cs y s t e m[ 28]
Poria cocos Ergosterone Enhances the secretion of the cytokines, interleukin-1β and TNF-α, which
enhances non-rapid eye movement sleep [29, 30]
have an antidepressant-like eﬀect through the inhibition of
monoamine oxidase, leading to an increase in the levels of
brainnorepinephrineanddopamineinamurinemodel[52].
P. cocos extract was reported to enhance the secretion of
cytokines, such as interleukin-1β and tumor necrotic factor
(TNF)-α, in human peripheral blood monocytes [29]. In
addition, these two cytokines have been shown to enhance
non-rapideyemovementsleep[30].InTable 6,wehavesum-
marized some important plants, which were prescribed, and
clarify the major constituents and pharmacologic activities
with sedative and hypnotic eﬀects. Because Suan-zao-ren-
tang is widely prescribed for the treatment of insomnia, it
is necessary to conduct randomized, double-blind, placebo-
controlled trials to assess its eﬃcacy and safety in patients
with well-deﬁned sleep disorders.
Jia-wei-xiao-yao-san was the second most commonly
used Chinese herbal formula for treating insomnia. Accord-
ing to one pilot clinical study [53], this formula can
improve climacteric symptoms in postmenopausal women,
such as anxiety, depression and insomnia. Other research
has showed that Jia-wei-xiao-yao-san increased plasma levels
of TNF-α in depressed menopausal patients [54]. Thus, this
herbal formula might regulate cytokine levels in the central
nervous system. In animal studies, Jia-wei-xiao-yao-san has
been shown to have anxiolytic or antidepressent-like eﬀects.
Moreover, the underlying mechanisms were associated with
the stimulation of the GABAA/benzodiazepine receptor
and increased hippocampal neurogenesis [55, 56]. It is
noteworthy that Kamisyoyo-san (a Japanese kampo formula
or Jia-wei-xiao-yao-san in Chinese) was reported to induce
adult respiratory distress syndrome after treating a case with
seborrheic dermatitis [57].
Another popular Chinese herbal formula used in treating
insomnia observed in our study was Chai-hu-jia-long-gu-
mu-li-tang (Saiko-ka-ryukotsu-borei-to in Japanese). This
formula can ameliorate sleep disorders by reducing exci-
tation in an animal model [58]. In addition, Chai-hu-
jia-long-gu-mu-li-tang has been reported to reduce stress-
induced brain monoamine release, and may be used to
treat depression [59, 60]. Gan-mai-da-zao-tang (Kanbaku-
taiso-to in Japanese) has been shown to inhibit the hyper-
excitability of neuronal membranes and may have sedative
eﬀects [61]. However, there are no reports regarding the use
of Tian-wang-bu-xin-dan, Wen-dan-tang, Gui-pi-tang, Zhi-
bai-di-huang-wan, Long-dan-xie-gan-tang (Yongdamsagan-
Tang in Japanese) and Qing-xin-lian-zi-yin in the treat-
ment of insomnia. In clinical practice, Long-dan-xie-gan-
tang is commonly prescribed to subjects with chronic
hepatitis in Taiwan [62]. Therefore, based on theories
of TCM, it is possible that Long-dan-xie-gan-tang could
treat insomnia manifested by the congestion of qi in the
liver.
In general, practitioners of Western medicine attempt to
determine the cause of insomnia and manage the patients
accordingly [63]. In contrast, the principles of diagnosis
and treatment of insomnia in Chinese medicine are pri-
marily based on the manifestations of the syndrome (i.e.,
the chief signs and symptoms of patients), from which
a corresponding prescription is provided [64]. The chief
symptoms and signs according to the TCM diagnosis include
appetite, thirst, mood, the color of the tongue and urine
and the state of the pulse. The prescription is often a
Chinese herbal formula. Moreover, one or more individual
Chinese herbs can be added empirically to treat some of
the other insomnia-related or non-related minor symptoms.
In a typical Chinese herbal formula, the prescription is
normally based on the concept of “emperor, minister,
assistant, and servant” [65]. This concept emphasizes that
a ministerial herb will have an additive or synergistic eﬀect
to the imperial herb (main ingredient), and an assistant
herb can reduce the adverse eﬀect of the imperial herb.
Thus, we speculate that Chinese herbal formulae used for
treating insomnia in this research present with their own
corresponding TCM syndrome. For instance, Suan-zao-ren-
tang is mainly used in treating insomnia with a syndrome
due to internal heat and eﬀulgent ﬁre caused by liver blood
deﬁciency. However, further investigation is warranted so
as to conﬁrm whether the corresponding TCM syndromeEvidence-Based Complementary and Alternative Medicine 7
associated with Suan-zao-ren-tang means that this type of
insomnia is the predominant syndrome in Taiwan or that
the patients with this type of syndrome are in favor of TCM
treatment.
In Taiwan, there are approximately 200 diﬀerent Chinese
herbal formulae and 300 individual Chinese herbs, which are
available for use and are produced by TCM pharmaceutical
companies that follow the regulation of good manufacturing
practices [66]. In our study, there was an average of 4.8
components in each Chinese herbal formula or single-
herb prescription for insomnia, perhaps representing the
complexity of symptoms related to insomnia recognized
by TCM physicians in Taiwan. According to our results,
the most commonly prescribed CHM drug combination
for treating insomnia was Suan-zao-ren-tang with Long-
dan-xie-gan-tang, while the most common triple drug
combination was Suan-zao-ren-tang, A. julibrissin and P.
multiﬂorum. Although Suan-zao-ren-tang and Long-dan-
xie-gan-tang are diﬀerent for their syndrome diﬀerentiation,
they are in the same prescription because it is diﬃcult
to clinically determine classical syndrome identiﬁcation.
However, we can also classify syndromes according to the
cause of the disease, which is the so-called “disease cause
syndrome identiﬁcation”. For example, congestion of qi in
thelivermaycauseliverblooddeﬁciency.Thus,forsyndrome
diﬀerentiation and treatment, there is a cause and eﬀect.
We may also add a tranquillizing medicine according to the
ancient medical textbooks. For example, A. julibrissin and P.
multiﬂorum or other modern and pharmacologically-proven
tranquillizers, may be added to this formula, that is, Scutel-
lariabaicalensis.Nevertheless,furtherinvestigation isneeded
to examine if these herbal combinations have synergic eﬀects
or other beneﬁcial eﬀects in treating insomnia.
5. Conclusions
In conclusion, based on the availability of electronic
healthcare claims data, a population-based pharmaco-
epidemiology survey of Chinese herbs for treating insomnia
was investigated. Thus, we now have a better understanding
of the use frequencies and patterns of CHM prescriptions for
the treatment of insomnia in a Chinese population. Never-
theless, the therapeutic eﬀects and safety of these Chinese
herbal formulae or individual herbs used in the treatment
of insomnia requires further elucidation through eﬃciency-
based clinical studies or well-designed randomized, double-
blind, placebo-controlled trials.
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